Clinical study of drug-eluting stents in acute coronary syndrome patients with diabetes and multivessel disease
10.3760/cma.j.issn.0254-9026.2020.06.007
- VernacularTitle:药物洗脱支架治疗糖尿病和多支血管病变的急性冠状动脉综合征患者临床研究
- Author:
Weijia QIU
1
;
Zheng PING
;
Yanan XIE
;
Xiong HUANG
;
Xuebin CAO
Author Information
1. 承德医学院研究生学院，承德 067000
- From:
Chinese Journal of Geriatrics
2020;39(6):636-638
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the safety and efficacy of drug-eluting stents(DES)in patients with acute coronary syndrome(ACS)complicated with diabetes and multivessel disease.Methods:A total of 80 patients with ACS who received XIENCE V Everolimus stent implantation in the heart center of the 82nd army hospital from January 2017 to October 2018 were retrospectively enrolled and analyzed.Patients were divided into the diabetic group(35 cases)and the non-diabetic group(45 cases)according to whether they were complicated with diabetes or mltivessel lesions.Stent implantation status within 12 months after PCI were compared between the groups.Results:(1)All stents were successfully implanted in the two groups.After coronary angiography re-examination within 12 months, there were no significant differences in the rate of stent restenosis(0.0% vs 2.2%), non-fatal myocardial infarction(2.9% vs.2.2%), or MACEs(2.9% vs.4.4%)between the diabetic and non-diabetic groups(all P>0.05). No patients died from cardiogenic causes in the two groups.(2)During the follow-up period, one patient was hospitalized for acute myocardial infarction in the diabetic group and one case died of an ascending aorta rupture. Conclusions:The safety and efficacy of XIENCE V DES in patients with diabetes and multivessel lesions are good, and the incidence of MACEs is low.
